These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 1883480)

  • 1. Anti-acetylcholine receptor antibodies decrease after thymectomy in patients with myasthenia gravis. Clinical correlations.
    Kuks JB; Oosterhuis HJ; Limburg PC; The TH
    J Autoimmun; 1991 Apr; 4(2):197-211. PubMed ID: 1883480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MuSK antibodies in AChR Ab-seropositive MG vs AChR Ab-seronegative MG.
    Ohta K; Shigemoto K; Kubo S; Maruyama N; Abe Y; Ueda N; Ohta M
    Neurology; 2004 Jun; 62(11):2132-3. PubMed ID: 15184636
    [No Abstract]   [Full Text] [Related]  

  • 3. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
    Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
    Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thymectomy in thymomatous and non-thymomatous myasthenia gravis: analysis of a cohort of 46 patients].
    Cabrera-Maqueda JM; Alba-Isasi MT; Hernández R; Arroyo-Tristán A; Morales-Ortiz A
    Rev Neurol; 2020 Mar; 70(6):213-219. PubMed ID: 32149381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and features of myasthenia gravis developing after thymectomy.
    Uzawa A; Kanai T; Oda F; Ozawa Y; Yasuda M; Kawaguchi N; Himuro K; Yoshino I; Kuwabara S
    Eur J Neurol; 2020 Jan; 27(1):175-180. PubMed ID: 31347231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylcholine receptor antibody and clinical response to thymectomy in myasthenia gravis.
    Vincent A; Newsom-Davis J; Newton P; Beck N
    Neurology; 1983 Oct; 33(10):1276-82. PubMed ID: 6684222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia gravis appearing after thymectomy.
    Sun XG; Wang YL; Liu YH; Zhang N; Yin XL; Zhang WJ
    J Clin Neurosci; 2011 Jan; 18(1):57-60. PubMed ID: 20888239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting response to thymectomy for myasthenia gravis.
    Rubin JW; Ellison RG; Moore HV; Pai GP
    J Thorac Cardiovasc Surg; 1981 Nov; 82(5):720-8. PubMed ID: 7300404
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-ryanodine receptor antibodies and FK506 in myasthenia gravis.
    Takamori M; Motomura M; Kawaguchi N; Nemoto Y; Hattori T; Yoshikawa H; Otsuka K
    Neurology; 2004 May; 62(10):1894-6. PubMed ID: 15159506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
    Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
    Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymectomy in myasthenia gravis. A review.
    Oosterhuis HJ
    Ital J Neurol Sci; 1983 Dec; 4(4):399-407. PubMed ID: 6370908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a thymectomy trial in nonthymomatous myasthenia gravis patients receiving immunosuppressive therapy.
    Wolfe GI; Kaminski HJ; Jaretzki A; Swan A; Newsom-Davis J
    Ann N Y Acad Sci; 2003 Sep; 998():473-80. PubMed ID: 14592916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymectomy in late-onset myasthenia gravis.
    Olanow CW; Lane RJ; Roses AD
    Arch Neurol; 1982 Feb; 39(2):82-3. PubMed ID: 7059304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 1. Relation to clinical parameters in 250 patients.
    Limburg PC; The TH; Hummel-Tappel E; Oosterhuis HJ
    J Neurol Sci; 1983 Mar; 58(3):357-70. PubMed ID: 6842264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic myasthenia gravis: immunological and clinical aspects.
    Skeie GO; Romi F
    Eur J Neurol; 2008 Oct; 15(10):1029-33. PubMed ID: 18717725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylcholine receptor antibodies in myasthenia gravis.
    Kornfeld P; Nall J; Smith H; Mittag TW; Bender AN; Ambinder EP; Horowitz SH; Papatestas AE; Gross H; Genkins G
    Muscle Nerve; 1981; 4(5):413-9. PubMed ID: 6974823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological implications of thymectomy for myasthenia gravis.
    Okumura M; Inoue M; Kadota Y; Hayashi A; Tokunaga T; Kusu T; Sawabata N; Shiono H
    Surg Today; 2010; 40(2):102-7. PubMed ID: 20107947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myasthenia gravis: immunological mechanisms and immunotherapy.
    Lewis RA; Selwa JF; Lisak RP
    Ann Neurol; 1995 May; 37 Suppl 1():S51-62. PubMed ID: 8968217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial predictors of development of pure red cell aplasia in myasthenia gravis after thymectomy.
    Suzuki S; Nogawa S; Tanaka K; Koto A; Fukuuchi Y; Kuwana M
    Clin Neurol Neurosurg; 2003 Dec; 106(1):16-8. PubMed ID: 14643910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of myasthenia gravis after thymectomy for thymoma].
    Spalek P
    Rozhl Chir; 1995 Mar; 74(2):100-2. PubMed ID: 7761941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.